Johnson & Johnson
JNJ
NYSE
$157.40
-$2.35-1.47%
Volume5,395,886
11/30/2021 1:25PM Eastern
Quotes delayed
| 10/03/2021 | 07/04/2021 | 04/04/2021 | 01/03/2021 | 09/27/2020 | |
|---|---|---|---|---|---|
| Revenue | 23.34B | 23.31B | 22.32B | 22.48B | 21.08B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.34B | 23.31B | 22.32B | 22.48B | 21.08B |
| Cost of Revenue | 7.23B | 7.57B | 7.04B | 7.78B | 6.94B |
| Gross Profit | 16.11B | 15.75B | 15.29B | 14.69B | 14.14B |
| SG&A Expenses | 5.85B | 5.94B | 5.26B | 6.71B | 5.34B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.50B | 16.90B | 15.48B | 18.53B | 15.12B |
| Operating Income | 6.84B | 6.41B | 6.84B | 3.95B | 5.97B |
| Income Before Tax | 3.85B | 6.66B | 7.43B | 1.65B | 4.40B |
| Income Tax Expenses | 182.00M | 384.00M | 1.23B | -91.00M | 847.00M |
| Earnings from Continuing Operations | 3.67B | 6.28B | 6.20B | 1.74B | 3.55B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.67B | 6.28B | 6.20B | 1.74B | 3.55B |
| EBIT | 6.84B | 6.41B | 6.84B | 3.95B | 5.97B |
| EBITDA | 8.65B | 8.25B | 8.74B | 5.89B | 7.78B |
| EPS Basic | 1.39 | 2.38 | 2.35 | 0.65 | 1.35 |
| Normalized Basic EPS | 1.63 | 1.56 | 1.65 | 0.91 | 1.46 |
| EPS Diluted | 1.37 | 2.35 | 2.32 | 0.65 | 1.33 |
| Normalized Diluted EPS | 1.61 | 1.54 | 1.63 | 0.91 | 1.44 |
| Average Basic Shares Outstanding | 2.63B | 2.63B | 2.63B | 2.67B | 2.63B |
| Average Diluted Shares Outstanding | 2.67B | 2.67B | 2.67B | 2.67B | 2.67B |
| Dividend Per Share | 1.06 | 1.06 | 1.01 | 1.01 | 1.01 |
| Payout Ratio | 76.11% | 44.46% | 42.91% | 152.93% | 74.82% |
